Patients With RA Receiving DMARDs Have Reduced COVID-19 Vaccine Immune Responses, Study Finds
A cross-sectional study finds that patients with rheumatoid arthritis receiving disease-modifying antirheumatic drugs (DMARDs) exhibit a reduced immune response to the COVID-19 vaccine compared with controls.